Matches in Nanopublications for { ?s ?p "[Apolipoprotein C-III (apo C-III) is a marker of cardiovascular disease risk associated with triglyceride (TG)-rich lipoproteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP59571.RAeiF6l8glQhRO45HEiH0PxkOviUGSSSBailPHrtLS-2w130_assertion description "[Apolipoprotein C-III (apo C-III) is a marker of cardiovascular disease risk associated with triglyceride (TG)-rich lipoproteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59571.RAeiF6l8glQhRO45HEiH0PxkOviUGSSSBailPHrtLS-2w130_provenance.
- NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_assertion description "[Apolipoprotein C-III (apo C-III) is a marker of cardiovascular disease risk associated with triglyceride (TG)-rich lipoproteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758337.RAYhEDpGgzk26a8tF2dBE0on3C5dW40aAsJU_kzNYLZy0130_provenance.
- assertion description "[Apolipoprotein C-III (apo C-III) is a marker of cardiovascular disease risk associated with triglyceride (TG)-rich lipoproteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Apolipoprotein C-III (apo C-III) is a marker of cardiovascular disease risk associated with triglyceride (TG)-rich lipoproteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP244443.RAAFPmItnJpkR9-vrJtNCSajabh1NdHYdsemBXjjH4c1Q130_assertion description "[Apolipoprotein C-III (apo C-III) is a marker of cardiovascular disease risk associated with triglyceride (TG)-rich lipoproteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244443.RAAFPmItnJpkR9-vrJtNCSajabh1NdHYdsemBXjjH4c1Q130_provenance.
- NP76571.RAHPYKnUXBa-nOreV_Vc7oLVZzi6FvSNH2PLB6aUIUJ0A130_assertion description "[Apolipoprotein C-III (apo C-III) is a marker of cardiovascular disease risk associated with triglyceride (TG)-rich lipoproteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP76571.RAHPYKnUXBa-nOreV_Vc7oLVZzi6FvSNH2PLB6aUIUJ0A130_provenance.
- NP470938.RAMMi_KQKZVcVQuBn42UquAddpx100838H7TWoRdAZivQ130_assertion description "[Apolipoprotein C-III (apo C-III) is a marker of cardiovascular disease risk associated with triglyceride (TG)-rich lipoproteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470938.RAMMi_KQKZVcVQuBn42UquAddpx100838H7TWoRdAZivQ130_provenance.
- NP89300.RAF1pZ45ruJJbFu6q_FwyTi1GdFtb4T3FRYEiGZyZPlFk130_assertion description "[Apolipoprotein C-III (apo C-III) is a marker of cardiovascular disease risk associated with triglyceride (TG)-rich lipoproteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89300.RAF1pZ45ruJJbFu6q_FwyTi1GdFtb4T3FRYEiGZyZPlFk130_provenance.